Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000275363 | SCV000342500 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001484138 | SCV001688548 | likely benign | Duchenne muscular dystrophy | 2024-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021251 | SCV005021396 | likely benign | Cardiovascular phenotype | 2024-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828250 | SCV002090421 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2021-07-19 | no assertion criteria provided | clinical testing |